Venatorx Pharmaceuticals, Inc.’s Post

We welcome Tamra Adams as our new Chief Financial Officer. With 25+ years of financial management experience, she delivers a wealth of experience to our senior leadership team. Learn more about Tamra and our other new leaders here: https://bit.ly/43dX3B3

  • No alternative text description for this image
Katie Laessig, MD

Seasoned drug development executive with 24 years combined regulatory, consulting, and industry experience. Particular expertise in antimicrobial product regulatory strategy and clinical development across all phases.

7mo

How wonderful, Tamra! Venatorx couldn’t have made a better choice. Let’s catch up soon!!

Like
Reply
Robert Hamilton

Sr. Retirement Plan Consultant at NFP

7mo

That's tremendous! Tamra - looking forward to catching up with you!!

Like
Reply
Katherine Squires, Ph.D.

Vice President of Preclinical Development at Altesa Bio

7mo

Congratulations!! I know you'll do great things there. Let's catch up soon!

Like
Reply
Karen Fusaro

SVP, Clinical Operations | Clinical Development Expert

7mo

Congratulations!!!! They are lucky to have you. Best wishes for much success.

Like
Reply

Congrats Tamra- they are so fortunate to have you on their team!

Like
Reply
Greg Mayes

President and CEO at Reunion Neuroscience

7mo

Congratulations! Huge news for Venatorx. You will make major contributions!

Like
Reply
Mary Beth Dorr

Senior Pharmaceutical Drug Development Professional, Retired

7mo

Welcome to Venatorx, Tamra. I look forward to working with you!

Like
Reply
Melissa Allaband

Vice President of Operations & Program Management

7mo

Congratulations Tamra! They are so lucky to have you!

Like
Reply
Steven Raz

CEO, Co-Founder & Managing Partner, Cornerstone Search Group——————- Angel Investor - Biotech

7mo

Congratulations! They are lucky to have you!!

Like
Reply
Mayan Katz

Partner, Tech & Life Sciences Group at Goodwin || M&A, VC, Israel, Digital Healthcare

7mo

Congratulations Tamra! They are lucky to have you

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics